about
The effects of sulodexide on both clinical and molecular parameters in patients with mixed arterial and venous ulcers of lower limbs.Upper extremity vein thrombosis: an alert symptom of breast cancer in elderly patients. Experience on personal casuistry and review of the literatureCombined medical, surgical and endovascular treatment of a giant cell arteritis case manifesting as upper limbs acute ischemia.Surgical resection of carotid body paragangliomas: 10 years of experience.Biomarkers in post-reperfusion syndrome after acute lower limb ischaemia.PredyCLU: a prediction system for chronic leg ulcers based on fuzzy logic; part I - exploring the venous side.Effects of glucocorticoids and tumor necrosis factor-alpha inhibitors on both clinical and molecular parameters in patients with Takayasu arteritis.Extracellular matrix assessment of infected chronic venous leg ulcers: role of metalloproteinases and inflammatory cytokines.Doxycycline speeds up healing of chronic venous ulcers.Angiosome-targeted revascularisation in diabetic foot ulcers.Application of platelet-rich gel to enhance healing of transmetatarsal amputations in diabetic dysvascular patients.Male breast cancer manifesting as cephalic vein thrombosis.Axillary vein thrombosis as the first clinical manifestation of inflammatory breast cancer: report of a case.Hyperhomocysteinaemia and chronic venous ulcers.Breast cancer and venous disease: a retrospective cohort study.Chronic venous leg ulcers are associated with high levels of metalloproteinases-9 and neutrophil gelatinase-associated lipocalin.Low molecular weight heparin improves healing of chronic venous ulcers especially in the elderly.Skin grafting followed by low-molecular-weight heparin long-term therapy in chronic venous leg ulcers.Increased plasma levels of metalloproteinase-9 and neutrophil gelatinase-associated lipocalin in a rare case of multiple artery aneurysm.Albumin administration prevents the onset of pressure ulcers in intensive care unit patients.Study on the efficacy of surgery of the superficial venous system and of compression therapy at early stages of chronic venous disease for the prevention of chronic venous ulceration.Effects of a new nutraceutical substance on clinical and molecular parameters in patients with chronic venous ulceration.Carotid body paragangliomas and matrix metalloproteinases.Resection of Carotid Body Tumors reduces arterial blood pressure. An underestimated neuroendocrine syndrome.The role of matrix metalloproteinases and neutrophil gelatinase-associated lipocalin in central and peripheral arterial aneurysms.Cilostazol prevents foot ulcers in diabetic patients with peripheral vascular disease.Role of matrix metalloproteinases in non-healing venous ulcers.A genetic study of chronic venous insufficiencyVaricocele in younger as risk factor for inguinal hernia and for chronic venous disease in older: preliminary results of a prospective cohort studyLow serum albumin level as an independent risk factor for the onset of pressure ulcers in intensive care unit patientsAltered metalloproteinase-9 expression as least common denominator between varicocele, inguinal hernia, and chronic venous disordersFrom varices to venous ulceration: the story of chronic venous disease described by metalloproteinases
P50
Q33632742-A7153C83-26B3-4BD4-BA21-C67999C9B3DFQ35051548-46C8CCFD-D829-48C6-8143-C26BA9978B8DQ35786299-0B1B3FC8-F985-4304-8ADD-DF261DB396AFQ38152059-EAF0AA6B-B88D-45CD-94DC-D361FFA126FFQ39084806-1496335A-2B24-4960-A87A-748D000755B4Q41145547-48D8FA74-1974-4C0C-863F-E6255C58F03FQ42132165-60004941-73BB-423C-B1F4-7D969E501FA0Q42224580-01FC0FF4-7ABC-4A5A-88A7-A6862FB0AE4CQ43642111-DA754196-FE1E-47C2-859E-11DAA075050EQ43719973-12743726-1641-429C-8D82-D780BEBB0B2FQ43934263-5E3EF049-478B-475C-81CE-A6D65D2DCCA7Q44451641-9F96FC2D-DE8A-4A47-AE9E-C077886C7E8BQ44774421-C08A9DC2-17A1-4284-B0C3-6081A7AE57CAQ44848247-FED62580-110C-49C4-A1AF-71A1563D5267Q45956662-7F4781A1-D5C1-429A-B446-424046E49F51Q46054346-92DD255B-D68B-4D23-AA85-4E7CDF1F3F68Q47246447-40401282-F361-42E8-8947-0AFC3440C3C6Q47348334-3DA7C163-8727-4F17-AF96-70EA49ED8539Q47674294-33B9DC95-30D7-43C4-A3B8-709EF50DA250Q48019668-02BC4AE6-6E15-4957-8ECE-CE6354379E2AQ48228960-44CCC226-2E16-471D-9932-4207CE365562Q48881971-9D40025C-6F65-495F-A47B-6C8FB83E29F6Q50802682-3C4B1BE6-60DD-4D91-9CA9-A8B58BBCC3FCQ50803612-B21BA5CA-7178-45D3-AF7E-6C33D9482F40Q50849329-DAA8C230-A546-4B31-8D82-0306B66B9B57Q50995559-FD30E426-C88E-4CD1-A4F4-4662E630E96EQ51189922-7592CE05-7812-43D5-BAEF-95433EC0EFBAQ84289604-4BD6A465-941D-4A5C-B570-F1749DB441A3Q85013527-C63C5868-32DE-4E86-87ED-4A3F4886B407Q85500270-F5F59A6D-2896-4294-9D65-71F08545C125Q86634761-34DBFC46-1CF8-4BCB-90BB-415CB2A02F05Q87489670-1E3D1748-4924-4888-A810-73DA7704802D
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Gianluca Buffone
@ast
Gianluca Buffone
@en
Gianluca Buffone
@es
Gianluca Buffone
@nl
Gianluca Buffone
@sl
type
label
Gianluca Buffone
@ast
Gianluca Buffone
@en
Gianluca Buffone
@es
Gianluca Buffone
@nl
Gianluca Buffone
@sl
prefLabel
Gianluca Buffone
@ast
Gianluca Buffone
@en
Gianluca Buffone
@es
Gianluca Buffone
@nl
Gianluca Buffone
@sl
P106
P1153
37005277300
P21
P31
P496
0000-0002-6998-5405